The existing authors conducted an open-label pilot examine that administered psilocybin to fifteen treatment-resistant tobacco/nicotine-dependent smokers, in the context of cognitive behavioral therapy for cigarette smoking cessation [58]. Individuals ended up administered ~0.29 mg/kg oral psilocybi